Mettler-Toledo International forward PE MTD
Share price divided by analysts' consensus earnings for the next twelve months, since 1997.
- Today, Oct 23, 2026
- 33.9×
- 10-year median
- 32.6×
- Against its 10-year history
- 62nd
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 21.6× to 47.2×
- Peer median
- 27.8×
Mettler-Toledo International's forward PE is 33.9× as of Oct 23, 2026.
That is above its ten-year median of 32.6×, close to the middle of its last ten years.
Over that time it ranged from 21.6× in May 2026 to 47.2× in Dec 2021.
The median for 10 diagnostics and research stocks of a similar size is 27.8×.
Forward PE over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 33.9× | 21.6× | 33.9× |
| 2025 | 31.9× | 24.5× | 34.2× |
| 2024 | 31.0× | 29.6× | 39.4× |
| 2023 | 33.0× | 26.7× | 41.1× |
| 2022 | 36.1× | 27.0× | 42.9× |
| 2021 | 47.2× | 33.6× | 47.2× |
| 2020 | 37.7× | 27.6× | 39.1× |
| 2019 | 36.4× | 24.6× | 38.5× |
| 2018 | 26.0× | 25.4× | 36.4× |
| 2017 | 32.6× | 26.0× | 36.9× |
| 2016 | 26.2× | 22.2× | 27.8× |
| 2015 | 25.2× | 21.4× | 26.9× |
| 2014 | 25.3× | 19.7× | 25.3× |
| 2013 | 22.3× | 19.1× | 23.3× |
| 2012 | 19.7× | 17.0× | 21.6× |
| 2011 | 17.4× | 15.9× | 24.4× |
| 2010 | 21.5× | 16.9× | 22.4× |
| 2009 | 19.7× | 10.4× | 20.0× |
| 2008 | 14.5× | 14.5× | 23.0× |
| 2007 | 24.4× | 20.8× | 26.0× |
Against its peers
Companies in Medical - Diagnostics & Research nearest Mettler-Toledo International's size, closest first, today.
| Company | Forward PE |
|---|---|
| MTDMettler-Toledo International | 33.9× |
| ILMNIllumina | 47.2× |
| DGXQuest Diagnostics | n/m |
| LHLabcorp | 17.4× |
| IDXXIDEXX Laboratories | 35.9× |
| WATWaters | 29.2× |
| IQVIQVIA | 20.5× |
| AAgilent Technologies | 26.4× |
| MEDPMedpace | n/m |
| RVTYRevvity | n/m |
| BIOBio-Rad Laboratories | n/m |
| Peer median | 27.8× |
Where Mettler-Toledo International ranks
What the forward PE tells you
Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.
Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.
More on Mettler-Toledo International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.